Assistant Professor, Medicine-Brigham and Women's Hospital, Harvard Medical School
Internal Medicine
Dr. Jessica L. Mega, MD
|
|
Give Review
Jessica Mega is an expert in the field of Internal Medicine. She went to Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care She received 1 awards: "Fellow (FACC)". Jessica L. Mega, MD is a published physician. She published 43 publications, including: 'PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.'
Publications
- PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
- Genetic risk, Coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
- Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
- Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments.
- World Heart federation expert consensus statement on antiplatelet therapy in east asian patients with ACS or undergoing PCI.
- Population and personalized medicine in the modern era.
- Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.
- Genotype-guided dosing of warfarin.
- Clinical Features, Use of Evidence-Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non-ST-Elevation Acute Coronary Sy...
- Antithrombotic treatment in transcatheter Aortic valve implantation: insights for cerebrovascular and bleeding events.
- Concomitant Administration of Clopidogrel With Statins or Calcium Channel Blockers: Insights From the TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcom...
- Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51.
- Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with Acute coronary syndromes in the ATLAS ACS-TIMI 46 trial.
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update.
- Comparison of the Efficacy and Safety of Two Rivaroxaban Doses in Acute Coronary Syndrome (from ATLAS ACS 2-TIMI 51).
- Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction: Results From the ATLAS ACS-2-TIMI-51 Trial (Anti-Xa Therapy to Lower Cardiovascu...
- Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular Disease.
- Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy.
- A New Era for Anticoagulation in Atrial Fibrillation.
- Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myo...
- Another step on the road to tailored antiplatelet therapy.
- Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.
- Clinical features and outcomes of women with unstable ischemic heart Disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevat...
- Identification of genetic variants associated with response to statin therapy.
- Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.
- Interaction between cigarette smoking and clinical benefit of clopidogrel.
- Cytochrome p-450 polymorphisms and response to clopidogrel.
- Thrombus precursor protein and clinical outcomes in patients with Acute coronary syndromes.
- Case records of the Massachusetts General Hospital. Case 36-2007. A 31-year-old woman with rash, fever, and Hypotension.
- Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation Myocardial infarction.
- Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.
- Dynamic aortic obstruction in a patient with Acute type B dissection.
- Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation Acute coronary syndromes: observations from the Platelet Receptor Inhib...
- B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation Myocardial infarction: an ENTIRE-TIMI-23 substudy.
- Rivaroxaban in patients with a recent Acute coronary syndrome.
- Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.
- Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.
- Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.
- Rivaroxaban versus placebo in patients with Acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.
- Increases in myocardial workload induced by rapid Atrial pacing trigger alterations in global metabolism.
Schools
Yale University
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Dissection
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Internal Medicine
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Massachusetts General Hospital -
Brigham and Women's Hospital -
Yale University School of Medicine
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336123215 |
| Last Name Of The Provider | MEGA |
| First Name Of The Provider | JESSICA |
| View All |
Similar Doctors
|
|
Dr. Sarah M. Bagley, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin M. McIntyre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen E. Thomas, MD |
|
|
Dr. Benjamin I. Bearnot, MD |
|
|
Dr. Alaina S. Ritter, MD |
|
|
Dr. Nawf H. Algublan, MD |
|
|
Dr. Stacy T. Charat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kate E. Koplan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle L. Hughes, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Francisco G. Aguilar Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Orvar Gunnarsson, MD
This Doctor is OpenDoctor Recommended.
|